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A 13-year-old intact male cat was submitted to castration after the finding of the enlargement of the right testis during the clinical
visit. Macroscopically, a nodule of 2 cm of diameter was observed on the cut surface of the enlarged testis. Histologically, the
nodule was composed by polyhedral to elongated cells with a large, eosinophilic, and vacuolated cytoplasm and small, round,
and dark nuclei.These cells were arranged in acinar structures and solid sheets.The tumour was diagnosed as a Leydig cell tumour.
Immunohistochemical analysis revealed that neoplastic cells were vimentin, calretinin, and melan-A positive, whereas a lack of
immunoreactivity to cytokeratins confirmed the diagnosis. To our knowledge, this is the first description of a feline Leydig cells
tumour without any concurrent testicular neoplasm or in a nonretained testis.
1. Introduction
Leydig cell tumours are neoplasms originating from the
interstitial Leydig cells of the testis. These tumours are
common in dogs and more rarely reported in other species
[1]. In cats, few cases of testicular tumors have been, up now,
described [2, 3] including some Leydig cell tumours located
in retained testis, in castrated cats, or with a concurrent
testicular neoplasm [4–7]. Here, we describe for the first time
a case of feline leydigioma occurring in a noncastrated cat and
without testicular retention.
2. Case Presentation
At the clinical exam, a 13-year-old intact European shorthair
male cat showed the increase in volume and firmness of
the right testis, while the left one was atrophic. Both were
normally located into the scrotum. Ultrasonographic investi-
gations allowed to identify an hypoechogenic nodule of 2 cm
of diameter in the enlarged testis. The cat did not present
behavioral alterations as aggressiveness, feminization, or
inappropriate urination. According to the owner’s will, the cat
was submitted to surgery to remove both the gonads.
On gross evaluation, themass of the right testiswas yellow
to brown-colored and firm and elastic at the palpation. The
neoplasm was well circumscribed and clearly demarcated
from the healthy testis. Tissue samples were fixed in 10%
neutral buffered formalin and processed by routine methods
for histological investigation. Four 𝜇m thick sections were
cut and stained with hematoxylin and eosin for micro-
scopic examination. Further tissue sections were prepared for
immunohistochemical staining. Immunohistochemistry was
performed with the biotin-streptavidin-peroxidase method
with primary antibodies against human pan-cytokeratins
(CK), vimentin,melan-A, and calretinin.The chromogenwas
3,3󸀠-diaminobenzidine (ImmPACT DAB, Vector Laborato-
ries, Burlingame, CA, USA) for all the antibodies (10min
at room temperature). Feline skin (for CK and vimentin),
adrenal gland (for calretinin), and amelanotic melanoma
(for melan-A) samples were used as positive control tissues.
As negative control, the primary antibodies were replaced
with nonimmune rabbit serum or replacing the primary
monoclonal antibodies with a murine subclass matched
unrelated antibodies. Immunohistochemical protocols and
results are described in Table 1.
Histological examination revealed the presence of solid
sheets and acinar structures composed by polyhedral to
elongated cells with a large, eosinophilic, and vacuolated
cytoplasm and small, dark, and round nuclei (Figure 1(a)).
These vacuoles were of different sizes and optically empty.
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Figure 1: Cat; testis; Leydig cell tumour. (a) Neoplastic polyhedral Leydig cells with a large, eosinophilic, and vacuolated cytoplasm and a
small and dark nuclei. These cells are arranged in solid sheets surrounded by a fine connective stroma in which a vascular structure can be
observed. Hematoxylin and Eosin stain, ×40. (b) Diffuse cytoplasmic immunoreactivity of neoplastic cells to vimentin. Biotin-streptavidin-
peroxidase method and hematoxylin counterstain. ×40. (c) Weak immunolabeling of tumour cells to calretinin antibody with some foci of
strong intensity. Biotin-streptavidin-peroxidasemethod and hematoxylin counterstain.×40. (d)Diffuse immunolabeling of neoplastic cells to
melan-A antibody. Biotin-streptavidin-peroxidase method and hematoxylin counterstain. ×40. Inserts: immunolabeling in normal testicular
tissue to the respective markers.
Table 1: Primary antibodies for immunohistochemistry and reactivity of feline Leydig cell tumour.
Antibody Type (clone) Company Dilution Incubation Antigen retrievala Immunoreactivity ofneoplastic cells
Cytokeratin MM (AE1/AE3) Santa Cruz 1 : 100 1 hour MW Negative
Vimentin MM (V9) Novocastra 1 : 100 1 hour MW Positive
Melan-A MM (A103) Ventana prediluted 1 hour MW Positive
Calretinin RP Cell Marque prediluted 1 hour MW Positive
MM: mouse monoclonal; RP: rabbit polyclonal; MW: microwave.
aAntigen retrieval: microwaved in 0.01M citrate buffer (pH 6.0) at 650W for 4 minutes and at 350W for 15 minutes.
Neoplastic cell sheets and acinar structures were surrounded
by a fine supporting connective stroma in which vascular
formations were often present. In some parts of the tumour,
small hemorrhagic foci were observed. Mitotic figures were
very rare and bipolar. Due to microscopic findings, the
neoformation was diagnosed as a Leydig cell tumour.
Immunohistochemistry showed a cytoplasmic positivity
of neoplastic cells to vimentin (Figure 1(b)) and the lack
of immunoreactivity to CK. These cells showed a weak and
focal calretinin expression (Figure 1(c)) and strong melan-
A cytoplasmic positivity (Figure 1(d)). These immunohisto-
chemical findings allowed to confirm the diagnosis of Leydig
cells tumour.
3. Discussion
Leydig cell tumours are common in dogs [1], whereas in cats
they are only rarely described. These reports concern inter-
stitial tumours occurred in ectopic testes or in cats previously
submitted to castration [4–7]. In one of these cases, the Leydig
cells tumour was associated with a Sertoli cell tumour [5].
Considering these reports, the tumour here described is the
first case of Leydig cell tumour affecting a normally located
testis and without any concurrent neoplasm.
The immunohistochemical panel allowed to better char-
acterize the nodule. Vimentin immunoreactivity of neoplas-
tic cells and the lack of CK expression has been previously
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described by Miller and colleagues in a interstitial tumour
associated with a Sertoli cell tumour in a castrated cat
[5]. Calretinin has been reported to be a useful immuno-
histochemical marker for normal and neoplastic human
Leydig cells [8, 9]. In the case here described, calretinin was
expressed mainly with a weak intensity with some foci of
strong expression, as yet reported by Miller and colleagues
[5].
Melan-A expression in Leydig cells has been reported in
human [9] and canine tumours [10]. Melan-A belongs to a
group of melanocytic differentiation antigens and its clone
A103 is used to detect steroid hormones producing cells,
even Leydig cells. For this reason, the research of melan-A
expression by immunohistochemistry may help to recognize
normal and neoplastic Leydig cells. Furthermore, melan-A
immunoreactivity could suggest the androgens production
by this tumour that can lead to alterations in the behavior
of the affected cat, with episodes of aggressiveness or inap-
propriate urination [5–7]. The cat bearing the tumour here
described did not show these signs, but the previous articles
reported this possibility.
In conclusion, this report describes a rare case of feline
genital system tumour with a novel clinical onset and with
a detailed histological and immunohistochemical characteri-
zation. On the basis of our findings, Leydig cell tumor may
be included in the differential diagnosis of feline testicular
pathologies.
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